Advanced search
Start date
Betweenand

Innovation in the Scaling and Integration of Genomic and Phenotypic Data of Brazilian Diversity on the gen-t Platform

Grant number:25/25741-0
Support Opportunities:Research Grants - Innovative Research in Small Business - PIPE
Start date: June 01, 2026
End date: May 31, 2028
Field of knowledge:Biological Sciences - Genetics - Human and Medical Genetics
Principal Investigator:Kelly Nunes
Grantee:Kelly Nunes
Company:Divegen Gestão e Tratamento de Dados Ltda
CNAE: Outras atividades de prestação de serviços de informação não especificadas anteriormente
Pesquisa e desenvolvimento experimental em ciências físicas e naturais
Atividades de apoio à gestão de saúde
Principal investigatorsTábita Hünemeier
Associated researchers: Bruno Pereira Fassina ; Lilian Kimura ; Renan Barbosa Lemes
Associated research grant:23/11678-0 - Development and implementation of data-mining modules for the identification of pharmacological targets in the Brazilian population genomics platform gen-t., AP.PIPE

Abstract

Despite the remarkable progress in genomic research, approximately 80% of the accumulated knowledge still derives from studies involving European populations, limiting our understanding of human genetic variability in other population groups. This gap represents not only a challenge but also an opportunity: understanding the genetic variability of the Brazilian population may reveal new therapeutic targets, biomarkers, and personalized health solutions, driving innovation in a more inclusive and representative way. In the PIPE Phase II, we took decisive steps to address this challenge by creating the Plataforma gen-t, which integrates genomic, clinical, and behavioral data from more than 22,000 Brazilians across all regions of the country. During this phase, we established the laboratory infrastructure to support large-scale data generation and developed genomic analysis pipelines capable of inferring ancestry, inbreeding (Runs of Homozygosity - ROH), human knockouts, genome-wide association studies (GWAS), admixture mapping, fine mapping, and pharmacogenomic variant analysis. All these pipelines are part of the data mining service of the Plataforma gen-t and demonstrate its potential to transform Brazil's genetic diversity into knowledge with both scientific and commercial value.The PIPE-Invest phase builds on this trajectory, focusing on the consolidation, expansion, and operational maturity of the Plataforma gen-t. Our main objectives are to: (i) expand the cohort to 50,000 participants by the end of 2027 through new recruitment campaigns and sample collection across different Brazilian regions; (ii) develop and implement an automated infrastructure for integrating and harmonizing laboratory, clinical, and behavioral data through pipelines that combine technical curation, semantic standardization, and artificial intelligence (LLMs), ensuring data quality and robust phenotype definitions for genomic analyses; (iii) validate and optimize the genomic pipelines developed in the previous phase (PIPE Phase II) for large-scale data scenarios, ensuring robustness, efficiency, and scalability; and (iv) implement a Trusted Research Environment (TRE) that will enable controlled, auditable, and user-friendly access for partners and clients to anonymized data, summary statistics, and analyses, in full compliance with the Brazilian General Data Protection Law (LGPD) and with complete traceability of analytical processes.By the end of this phase, the Plataforma gen-t will stand as a mature and fully operational infrastructure, capable of generating high-impact scientific insights, accelerating discoveries, and transforming Brazil's genetic diversity into innovative health solutions-positioning itself as a unique resource in both national and global markets. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)